Doctor Doug Will See You Now!

 

In an era where mental health challenges are front and center, the role of leaders like Douglas Newton, MD, MPH, becomes increasingly pivotal. As the Chief Medical Officer at Rula, Doctor Doug is at the forefront of a healthcare revolution, navigating the complexities of behavioral health with a systems-focused approach. This episode of “Healthcare Rethink,” hosted by Brian Urban, examines how Newton redefines mental health care by merging technology with personalized patient care.

Doctor Doug discusses his journey from focusing on infectious diseases to becoming a child psychiatrist and eventually leading Rula. The conversation explores how Rula, formerly known as PATH, differentiates itself in a crowded market by being a behavioral health provider group enabled by technology rather than driven by it. Newton emphasizes the importance of using technology to support, not replace, the human connection in mental health care, ensuring that quality care is always at the forefront.

As the episode unfolds, Doctor Doug shares insights into Rula’s strategy for addressing mental health across diverse populations and varying age groups. With a focus on preventing loneliness and isolation, Newton underscores the importance of early interventions and continuous support for maintaining wellness. The discussion also touches on the innovative ways Rula integrates AI and technology to enhance patient care without compromising the crucial human element in behavioral health.

For those interested in the future of mental health care, this episode offers a glimpse into how leaders like Newton are shaping a more connected, compassionate, and effective healthcare system.

Recent Episodes

In this impactful episode of the ConCensis podcast, host Yasmeen Hassan sits down with Robby Miller, Sterile Processing Manager at St. Joseph’s Hospital Medical Center, to explore how artificial intelligence is revolutionizing the field of sterile processing. With nearly 30 years of experience in healthcare, Miller shares his journey from EMT to SPD leader, offering…

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

In an era where precision and predictability define the future of oncology, organoid technology is emerging as a transformative tool in drug discovery. These miniature, lab-grown 3D tissues mirror real human biology more closely than traditional 2D models or even animal systems, offering researchers the potential to predict patient-specific drug responses. As organoids become more…